Stryker Corp (SYK) stock
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/308% below fair value
$317.54+6.82 (+2.19%)
Close on Nov 17, 2026Market cap $120.88BP/E 33.8Yield –
Stryker ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Stryker's ebitda for the twelve months ending Sep 30, 2026 was $7.05B, up 36.5% year over year. For fiscal 2025 it was $6.46B, up 26.3% from the year before. Over ten years it grew 10.2% a year on average. The highest annual figure on record is $6.46B in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.46B | +26.3% |
| FY2024 | Dec 31, 2024 | $5.12B | -2.2% |
| FY2023 | Dec 31, 2023 | $5.23B | +26.9% |
| FY2022 | Dec 31, 2022 | $4.12B | +6.8% |
| FY2021 | Dec 31, 2021 | $3.86B | +16.9% |
| FY2020 | Dec 31, 2020 | $3.30B | -12.2% |
| FY2019 | Dec 31, 2019 | $3.76B | +7.3% |
| FY2018 | Dec 31, 2018 | $3.50B | +11.0% |
| FY2017 | Dec 31, 2017 | $3.16B | +7.8% |
| FY2016 | Dec 31, 2016 | $2.93B | +19.4% |
| FY2015 | Dec 31, 2015 | $2.45B | +33.8% |
| FY2014 | Dec 31, 2014 | $1.83B | +3.7% |
| FY2013 | Dec 31, 2013 | $1.77B | -20.7% |
| FY2012 | Dec 31, 2012 | $2.23B | +2.8% |
| FY2011 | Dec 31, 2011 | $2.17B | +0.3% |
| FY2010 | Dec 31, 2010 | $2.16B | +9.2% |
| FY2009 | Dec 31, 2009 | $1.98B | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.43B | -6.9% |
| Q2 FY2026 | Jun 30, 2026 | $2.06B | +37.5% |
| Q1 FY2026 | Mar 31, 2026 | $1.33B | +11.3% |
| Q4 FY2025 | Dec 31, 2025 | $2.22B | +139.6% |
| Q3 FY2025 | Sep 30, 2025 | $1.54B | +5.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.50B | +6.8% |
| Q1 FY2025 | Mar 31, 2025 | $1.20B | -9.7% |
| Q4 FY2024 | Dec 31, 2024 | $927.00M | – |
| Q3 FY2024 | Sep 30, 2024 | $1.46B | – |
| Q2 FY2024 | Jun 30, 2024 | $1.41B | – |
| Q1 FY2024 | Mar 31, 2024 | $1.33B | – |
See a number that looks wrong?